share_log

新銳醫藥:於二零二四年七月十六日舉行之股東特別大會之投票結果

NEW RAY MEDIC: POLL RESULTS OF THE SPECIAL GENERAL MEETINGHELD ON 16 JULY 2024

HKEX ·  Jul 16 20:37

Summary by Moomoo AI

新銳醫藥國際控股有限公司(「新銳醫藥」)於2024年7月16日召開股東特別大會,會上通過了一項普通決議案。該決議案涉及批准買賣協議及其項下擬進行的交易,並授權任何一名董事處理相關事宜。在出席會議的股東中,有429,438,400股票(佔出席股東所持股份的100%)投票贊成,無票反對。此次決議案的通過,使得公司得以進行相關的交易。股東特別大會當天,公司已發行的股份總數為1,671,846,657股,且公司未持有任何庫存股份。所有董事均親身或以電子方式出席了會議,並無股東須放棄投票或表明有意反對決議案。股東特別大會的監票員為卓佳證券登記有限公司。新銳醫藥主席、行政總裁兼執行董事王秋勤女士於會後發表公告。
新銳醫藥國際控股有限公司(「新銳醫藥」)於2024年7月16日召開股東特別大會,會上通過了一項普通決議案。該決議案涉及批准買賣協議及其項下擬進行的交易,並授權任何一名董事處理相關事宜。在出席會議的股東中,有429,438,400股票(佔出席股東所持股份的100%)投票贊成,無票反對。此次決議案的通過,使得公司得以進行相關的交易。股東特別大會當天,公司已發行的股份總數為1,671,846,657股,且公司未持有任何庫存股份。所有董事均親身或以電子方式出席了會議,並無股東須放棄投票或表明有意反對決議案。股東特別大會的監票員為卓佳證券登記有限公司。新銳醫藥主席、行政總裁兼執行董事王秋勤女士於會後發表公告。
New Ray Medic International Holdings Limited ('New Ray Medic') held a special general meeting of shareholders on July 16, 2024, during which an ordinary resolution was passed. The resolution concerns the approval of a purchase agreement and related transactions, and authorizes any director to handle related matters. Among the shareholders who attended the meeting, 429,438,400 shares (100% of the shares held by attending shareholders) voted in favor, with no votes against. The passage of this resolution allows the company to carry out the relevant transactions. On the day of the special general meeting, the total number of shares issued by the company was 1,671,846,657, and the company did not hold any inventory shares. All directors attended the meeting in person or by electronic means, and no shareholder was required to abstain from voting or indicate opposition to the resolution. The scrutineer for the special general meeting of shareholders was Zhuojia Securities Registration Limited. Ms. Wang Qiuqin, Chairman, CEO and Executive Director of New Ray Medic issued a statement after the meeting.
New Ray Medic International Holdings Limited ('New Ray Medic') held a special general meeting of shareholders on July 16, 2024, during which an ordinary resolution was passed. The resolution concerns the approval of a purchase agreement and related transactions, and authorizes any director to handle related matters. Among the shareholders who attended the meeting, 429,438,400 shares (100% of the shares held by attending shareholders) voted in favor, with no votes against. The passage of this resolution allows the company to carry out the relevant transactions. On the day of the special general meeting, the total number of shares issued by the company was 1,671,846,657, and the company did not hold any inventory shares. All directors attended the meeting in person or by electronic means, and no shareholder was required to abstain from voting or indicate opposition to the resolution. The scrutineer for the special general meeting of shareholders was Zhuojia Securities Registration Limited. Ms. Wang Qiuqin, Chairman, CEO and Executive Director of New Ray Medic issued a statement after the meeting.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more